Ibex Wealth Advisors Abb Vie Inc. Transaction History

Ibex Wealth Advisors

$1.17 Billion
Q3 2024

A detailed history of Ibex Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Ibex Wealth Advisors holds 55,687 shares of ABBV stock, worth $10 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

55,687

Previous 52,556 5.96%

Holding current value

$10 Million

Previous $9.01 Million 22.0%

% of portfolio

0.94%

Previous 1.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$163.84 - $199.33 $512,983 - $624,102	3,131 Added 5.96%	55,687 $11 Million
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $304,781 - $355,916	1,969 Added 3.89%	52,556 $9.01 Million
Q1 2024 Apr 18, 2024	BUY	$159.82 - $182.1 $8.08 Million - $9.2 Million	50,538 Added 103138.78%	50,587 $8.18 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $6.9 Million - $7.77 Million	-50,121 Reduced 99.9%	49 $7.66 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $642,033 - $743,247	-4,806 Reduced 8.74%	50,170 $7.48 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $634,693 - $730,944	4,389 Added 8.68%	54,976 $8.76 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $1.85 Million - $2.21 Million	-13,351 Reduced 20.88%	50,587 $8.18 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $1.8 Million - $2.06 Million	13,392 Added 26.49%	63,938 $8.58 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $111,609 - $141,892	811 Added 1.63%	50,546 $7.74 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $617,798 - $766,513	4,681 Added 10.39%	49,735 $8.06 Million
Q4 2021 Feb 22, 2022	BUY	$107.43 - $135.93 $518,027 - $655,454	4,822 Added 11.99%	45,054 $6.1 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $326,860 - $371,036	3,072 Added 8.27%	40,232 $4.34 Million
Q2 2021 Aug 20, 2021	BUY	$105.21 - $117.21 $3.91 Million - $4.36 Million	37,160 New	37,160 $4.19 Million
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $2.44 Million - $3.29 Million	-30,319 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $112,456 - $131,986	1,309 Added 4.51%	30,319 $2.66 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.13 Million - $2.85 Million	29,010 New	29,010 $2.85 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $1.91 Million - $2.44 Million	-29,038 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $1.37 Million - $1.61 Million	17,743 Added 157.09%	29,038 $2.34 Million
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $879,315 - $1.08 Million	11,295 New	11,295 $1.04 Million
Q1 2018 Jun 13, 2018	SELL	$92.01 - $123.21 $1.54 Million - $2.07 Million	-16,767 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $201,151 - $220,579	2,246 Added 15.47%	16,767 $1.67 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.01 Million - $1.3 Million	14,521	14,521 $1.32 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Wealth Advisors with notifications on news.

Account

Ibex Wealth Advisors Abb Vie Inc. Transaction History